TEPEZZA 500 mg / 500 mg / 1 flacon(s)
7680697950012
CH-69795
L04AG13
07.15.0.
1 / 3
google
Details
- Product number
- 6979501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- teprotumumabum 500 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, pro vitro.
Articles (1)
Tepezza 500 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69795
- Drug name
- Tepezza, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L04AG13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 30/04/2025
- Authorization expiration date
- 29/04/2030
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TEPEZZA 500 mg / 500 mg / 1 flacon(s)
- Description (DE)
- TEPEZZA 500 mg / 500 mg / 1 Durchstechflasche(n)
- Market launch
- 13/02/2026
- Narcotic (BTM)
- No